Goswami J, Cardona JF, Caso J, Hsu DC, et al. Safety, Tolerability, and Immunogenicity of Revaccination with mRNA-1345, an mRNA Vaccine Against RSV, Administered 12 Months Following a Primary Dose in Adults Aged >/=50 Years. Clin Infect Dis 2025 Sep 23:ciaf515. doi: 10.1093.
PMID: 40988124